Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury

Abbadie, 2003, Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2, Proc. Natl. Acad. Sci. USA, 100, 7947, 10.1073/pnas.1331358100 Arruda, 2000, Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain, Brain Res., 879, 216, 10.1016/S0006-8993(00)02807-9 Cherny, 1994, Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies, Neurology, 44, 857, 10.1212/WNL.44.5.857 Clark, A.K., Gentry, C., Bradbury, E.J., McMahon, S.B., Malcangio, M., 2006. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain epub. Colburn, 1997, Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat, J. Neuroimmunol., 79, 163, 10.1016/S0165-5728(97)00119-7 Covino, 1980, Ethical standards for investigations of experimental pain in animals. The Committee for Research and Ethical Issues of the International Association for the Study of Pain, Pain, 9, 141, 10.1016/0304-3959(80)90002-0 Coyle, 1998, Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior, Glia, 23, 75, 10.1002/(SICI)1098-1136(199805)23:1<75::AID-GLIA7>3.0.CO;2-3 DeLeo, 1987, Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285), J. Cereb. Blood Flow Metab., 7, 745, 10.1038/jcbfm.1987.129 DeLeo, 1997, Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy, Brain Res., 759, 50, 10.1016/S0006-8993(97)00209-6 DeLeo, 2006, The tetrapartite synapse: path to CNS sensitization and chronic pain, Pain, 122, 17, 10.1016/j.pain.2006.02.034 Dellemijn, 1997, Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain, Lancet, 349, 753, 10.1016/S0140-6736(96)09024-1 Eriksson, 1997, A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat, Exp. Brain Res., 114, 393, 10.1007/PL00005649 Fanciullo, 2002, An observational study on the prevalence and pattern of opioid use in 25,479 patients with spine and radicular pain, Spine, 27, 201, 10.1097/00007632-200201150-00016 Giulian, 1994, Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture, Neurochem. Int., 25, 227, 10.1016/0197-0186(94)90066-3 Hains, 2006, Activated microglia contribute to the maintenance of chronic pain after spinal cord injury, J. Neurosci., 26, 4308, 10.1523/JNEUROSCI.0003-06.2006 Haydon, 2001, GLIA: listening and talking to the synapse, Nat. Rev. Neurosci., 2, 185, 10.1038/35058528 Kimelberg, 2004, The problem of astrocyte identity, Neurochem. Int., 45, 191, 10.1016/j.neuint.2003.08.015 Kittner, 1997, Clinical trials in dementia with propentofylline, Ann. N Y Acad. Sci., 826, 307, 10.1111/j.1749-6632.1997.tb48481.x Klein, 1997, Impaired neuroglial activation in interleukin-6 deficient mice, Glia, 19, 227, 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W Kloss, 2001, Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture, Exp. Neurol., 168, 32, 10.1006/exnr.2000.7575 Ledeboer, 2005, Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation, Pain, 115, 71, 10.1016/j.pain.2005.02.009 Linderoth, 2006, Mechanisms of spinal cord stimulation in painful syndromes: role of animal models, Pain Med., 7, S14, 10.1111/j.1526-4637.2006.00119.x Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 McRae, 1998, Properties of activated microglia and pharmacologic interference by propentofylline, Alzheimer Dis. Assoc. Disord., 12, S15 Meskini, 1994, Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation, Biochem. Pharmacol., 47, 781, 10.1016/0006-2952(94)90477-4 Nagata, 1985, In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity, Arzneimittelforschung, 35, 1034 Narita, 2006, Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice, J. Neurochem., 97, 1337, 10.1111/j.1471-4159.2006.03808.x Parkinson, 1991, Effects of propentofylline on adenosine A1 and A2 receptors and nitrobenzylthioinosine-sensitive nucleoside transporters: quantitative autoradiographic analysis, Eur. J. Pharmacol., 202, 361, 10.1016/0014-2999(91)90279-Y Raghavendra, 2003, Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy, J. Pharmacol. Exp. Ther., 306, 624, 10.1124/jpet.103.052407 Raghavendra, 2003, Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines, Pain, 104, 655, 10.1016/S0304-3959(03)00138-6 Rother, 1998, Propentofylline in the treatment of Alzheimer’s disease and vascular dementia: a review of phase III trials, Dement. Geriatr. Cogn. Disord., 9, 36, 10.1159/000051188 Schubert, 1998, Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference, J. Neural. Trans., 167, 10.1007/978-3-7091-7508-8_16 Schubert, 1997, Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline, Ann. N Y Acad. Sci., 826, 337, 10.1111/j.1749-6632.1997.tb48484.x Schubert, 1998, Interfering with the pathologic activation of microglial cells and astrocytes in dementia, Alzheimer Dis. Assoc. Disord., 12, S21 Schumacher, 2004, Opioid Analgesics and Antagonists, 497 Si, 1996, Adenosine and propentofylline inhibit the proliferation of cultured microglial cells, Exp. Neurol., 137, 345, 10.1006/exnr.1996.0035 Svensson, 1993, Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection, J. Neurosci. Res., 35, 373, 10.1002/jnr.490350404 Svensson, 1993, The response of central glia to peripheral nerve injury, Brain Res. Bull., 30, 499, 10.1016/0361-9230(93)90284-I Sweitzer, 2001, Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain, Neuroscience, 103, 529, 10.1016/S0306-4522(00)00574-1 Sweitzer, 2001, Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain, J. Pharmacol. Exp. Ther., 297, 1210 Tanga, 2004, Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain, Neurochem. Int., 45, 397, 10.1016/j.neuint.2003.06.002 Tawfik, 2006, Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the differentiated phenotype., Glia, 54, 193, 10.1002/glia.20365 Watkins, 2003, GLIA: a novel drug discovery target for clinical pain, Nat. Rev. Drug Discov., 2, 973, 10.1038/nrd1251 Watkins, 2001, Glial activation: a driving force for pathological pain, Trends Neurosci., 24, 450, 10.1016/S0166-2236(00)01854-3